Capromorelin

Capromorelin is an orally active ghrelin receptor agonist, approved for veterinary use as an appetite stimulant. Researchers study its mechanism of action in mimicking ghrelin to promote appetite and lean body mass.

In the literature, Capromorelin appears most often in work focused on appetite control, muscle growth and metabolism. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.

Capromorelin is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.